Pharmaceutical Business Review
Anonymous User | Login

Dow Finalises Sale To Arkema Of Acrylic Acid, Esters, Specialty Latex Assets In North America

Published: 25-Jan-2010

Arkema and the Dow Chemical have closed Dow’s divestiture to Arkema of its acrylic acid and esters business located at Clear Lake, Texas and its UCAR Emulsion Systems specialty latex business in North America. The transaction has a fair value consideration of $50m.

Reportedly, on August 3, the two companies announced they entered into the agreement, through which Dow will meet FTC-required divestitures related to its acquisition of Rohm and Haas. The divestiture recently received final approval from the US Federal Trade Commission.

Arkema which already operates a world-scale acrylic monomer production site, in France (Carling, Moselle) and a second site in the US (Bayport, Texas), will strengthen its positions in the acrylics market where main applications include paints and coatings, superabsorbents, water treatment, paper and textile.

Dow is a chemical company that combines the power of science and technology with the 'Human Element' to constantly improve what is essential to human progress. The company delivers a range of products and services to customers in approximately 160 countries, and provide products which include fresh water, food and pharmaceuticals to paints, packaging and personal care products.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Valsynthese

Hazardous Chemistry in Safe Hands ...

USB

Products from Affymetrix ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

TAPI

A Leading Global Supplier of Active Pharmaceutical Ingredients ...

Pharma IQ

Workshops, Conferences and Training Courses for Pharmaceutical Professionals ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

CaseBase Management

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

SafetyBase Interchange

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

ClinicalBase Trial

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

Reliable Prediction of White Plasma Levels

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Kinetics and Metabolism

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Drug Safety Evaluation

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

FMC Corporation

FMC Corporation (FMC) is a diversified chemical company offering solutions, application ...

Bayer AG

Bayer AG (Bayer) is the management holding company for the Bayer Group. The company car ...

E. I. du Pont de Nemours and Company

E. I. du Pont de Nemours and Company (DuPont)) is a science and technology company that ...

The Dow Chemical Company

The Dow Chemical Company (Dow) is a science and technology company that provides a wide ...

Rhodia S.A.

Rhodia S.A. is principally engaged developing, manufacturing and production of specialt ...

Suppliers Product News

Accovion Selects Liquent Insight Publisher

Contract Research Organization Chooses Thomson Reuters Software Solution

Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available

Free Access Given to Support the Global R&D and Healthcare Community

Thomson Reuters Announces the Availabilty of Three Pharma Matters Reports Covering January - March 2009

Quarterly Reports Use Market Intelligence and Competitive Analysis from Thomson Reuters to Highlight Developments in the Global Pharmaceutical Industry

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address